[Federal Register Volume 78, Number 126 (Monday, July 1, 2013)]
[Notices]
[Pages 39254-39255]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-15724]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-65-2013]


Notification of Proposed Production Activity; Subzone 7G; 
Schering-Plough Products, L.L.C. (Pharmaceutical Products); Las 
Piedras, Puerto Rico

    Schering-Plough Products, L.L.C. (Schering-Plough), operator of 
Subzone 7G, submitted a notification of proposed production activity to 
the FTZ Board for its facility in Las Piedras, Puerto Rico. The 
notification conforming to the requirements of the regulations of the

[[Page 39255]]

FTZ Board (15 CFR 400.22) was received on June 17, 2013.
    Schering-Plough currently has authority to produce certain 
pharmaceutical products and their intermediates within Subzone 7G. The 
current request would add the production of suvorexant pharmaceutical 
tablets for the treatment of insomnia using a proprietary active 
ingredient, an orexin receptor antagonist, to the scope of authority. 
Pursuant to 15 CFR 400.14(b), additional FTZ authority would be limited 
to the specific foreign-status material and the specific finished 
product listed in the submitted notification described here and 
subsequently authorized by the FTZ Board.
    Production under FTZ procedures could exempt Schering-Plough from 
customs duty payments on the foreign status material used in export 
production. On its domestic sales, Schering-Plough would be able to 
choose the duty rate during customs entry procedures that applies to 
the suvorexant tablets (duty-free) for the additional foreign-status 
active ingredient (duty rate, 6.5%) and for the foreign status inputs 
in the existing scope of authority. Customs duties also could possibly 
be deferred or reduced on foreign status production equipment.
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive Secretary at the address 
below. The closing period for their receipt is August 12, 2013.
    A copy of the notification will be available for public inspection 
at the Office of the Executive Secretary, Foreign-Trade Zones Board, 
Room 21013, U.S. Department of Commerce, 1401 Constitution Avenue NW., 
Washington, DC 20230-0002, and in the ``Reading Room'' section of the 
Board's Web site, which is accessible via www.trade.gov/ftz.

FOR FURTHER INFORMATION CONTACT: Diane Finver at [email protected] 
or (202) 482-1367.

    Dated: June 25, 2013.
Elizabeth Whiteman,
Acting Executive Secretary.
[FR Doc. 2013-15724 Filed 6-28-13; 8:45 am]
BILLING CODE 3510-DS-P